|
1
|
Foray N: Claudius Regaud (1870–1940): A
pioneer of radiobiology and radiotherapy. Cancer/Radiothérapie.
16:315–321. 2012.(In French). View Article : Google Scholar
|
|
2
|
Rycaj K and Tang DG: Cancer stem cells and
radioresistance. Int J Radiat Biol. 90:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blazek ER, Foutch JL and Maki G: Daoy
medulloblastoma cells that express CD133 are radioresistant
relative to CD133-cells and the CD133+ sector is enlarged by
hypoxia. Int J Radiat Oncol Biol Phys. 67:1–5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Jong MC, Pramana J, van der Wal JE,
Lacko M, Peutz-Kootstra CJ, de Jong JM, Takes RP, Kaanders JH, van
der Laan BF, Wachters J, et al: CD44 expression predicts local
recurrence after radiotherapy in larynx cancer. Clin Cancer Res.
16:5329–5338. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24 (−/low)/CD44+ breast cancer-initiating cells to
radiation. J Natl Cancer Inst. 98:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du Z, Qin R, Wei C, Wang M, Shi C, Tian R
and Peng C: Pancreatic cancer cells resistant to chemoradiotherapy
rich in ‘stem-cell-like’ tumor cells. Dig Dis Sci. 56:741–750.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou BB, Zhang H, Damelin M, Geles KG,
Grindley JC and Dirks PB: Tumour-initiating cells: Challenges and
opportunities for anticancer drug discovery. Nat Rev Drug Discov.
8:806–823. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee HE, Kim JH, Kim YJ, Choi SY, Kim SW,
Kang E, Chung IY, Kim IA, Kim EJ, Choi Y, et al: An increase in
cancer stem cell population after primary systemic therapy is a
poor prognostic factor in breast cancer. Br J Cancer.
104:1730–1738. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anderson K, Lutz C, van Delft FW, Bateman
CM, Guo Y, Colman SM, Kempski H, Moorman AV, Titley I, Swansbury J,
et al: Genetic variegation of clonal architecture and propagating
cells in leukaemia. Nature. 469:356–361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mullighan CG, Phillips LA, Su X, Ma J,
Miller CB, Shurtleff SA and Downing JR: Genomic analysis of the
clonal origins of relapsed acute lymphoblastic leukemia. Science.
322:1377–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Civenni G, Walter A, Kobert N,
Mihic-Probst D, Zipser M, Belloni B, Seifert B, Moch H, Dummer R,
van den Broek M and Sommer L: Human CD271-positive melanoma stem
cells associated with metastasis establish tumor heterogeneity and
long-term growth. Cancer Res. 71:3098–3109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oravecz-Wilson KI, Philips ST, Yilmaz OH,
Ames HM, Li L, Crawford BD, Gauvin AM, Lucas PC, Sitwala K, Downing
JR, et al: Persistence of leukemia-initiating cells in a
conditional knockin model of an imatinib-responsive
myeloproliferative disorder. Cancer Cell. 16:137–148. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao C, Chen A, Jamieson CH, Fereshteh M,
Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, et al:
Hedgehog signalling is essential for maintenance of cancer stem
cells in myeloid leukaemia. Nature. 458:776–779. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schatton T, Murphy GF, Frank NY, Yamaura
K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM,
Weishaupt C, et al: Identification of cells initiating human
melanomas. Nature. 451:345–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai
P, Chu PW, Lam CT, Poon RT and Fan ST: Significance of CD90+ cancer
stem cells in human liver cancer. Cancer Cell. 13:153–166. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eriksson M, Guse K, Bauerschmitz G,
Virkkunen P, Tarkkanen M, Tanner M, Hakkarainen T, Kanerva A,
Desmond RA, Pesonen S and Hemminki A: Oncolytic adenoviruses kill
breast cancer initiating CD44+CD24-/low cells. Mol Ther.
15:2088–2093. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang H, Gomez-Manzano C, Aoki H, Alonso
MM, Kondo S, McCormick F, Xu J, Kondo Y, Bekele BN, Colman H, et
al: Examination of the therapeutic potential of Delta-24-RGD in
brain tumor stem cells: Role of autophagic cell death. J Natl
Cancer Inst. 99:1410–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schatton T, Frank NY and Frank MH:
Identification and targeting of cancer stem cells. Bioessays.
31:1038–1049. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ishikawa F, Yoshida S, Saito Y, Hijikata
A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N,
et al: Chemotherapy-resistant human AML stem cells home to and
engraft within the bone-marrow endosteal region. Nat Biotechnol.
25:1315–1321. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sullivan JP, Spinola M, Dodge M, Raso MG,
Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, et
al: Aldehyde dehydrogenase activity selects for lung adenocarcinoma
stem cells dependent on notch signaling. Cancer Res. 70:9937–9948.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim MP, Fleming JB, Wang H, Abbruzzese JL,
Choi W, Kopetz S, McConkey DJ, Evans DB and Gallick GE: ALDH
activity selectively defines an enhanced tumor-initiating cell
population relative to CD133 expression in human pancreatic
adenocarcinoma. PLoS One. 6:e206362011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu L, McArthur C and Jaffe RB: Ovarian
cancer stem-like side-population cells are tumourigenic and
chemoresistant. Br J Cancer. 102:1276–1283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma S, Chan KW, Lee TK, Tang KH, Wo JY,
Zheng BJ and Guan XY: Aldehyde dehydrogenase discriminates the
CD133 liver cancer stem cell populations. Mol Cancer Res.
6:1146–1153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA and Katz RL: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Broadley KW, Hunn MK, Farrand KJ, Price
KM, Grasso C, Miller RJ, Hermans IF and McConnell MJ: Side
population is not necessary or sufficient for a cancer stem cell
phenotype in glioblastoma multiforme. Stem Cells. 29:452–461. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Alison MR, Lin WR, Lim SM and Nicholson
LJ: Cancer stem cells: In the line of fire. Cancer Treat Rev.
38:589–598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rich JN and Bao S: Chemotherapy and cancer
stem cells. Cell Stem Cell. 1:353–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Morrison R, Schleicher SM, Sun Y, Niermann
KJ, Kim S, Spratt DE, Chung CH and Lu B: Targeting the mechanisms
of resistance to chemotherapy and radiotherapy with the cancer stem
cell hypothesis. J Oncol. 2011:9418762011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hill RP, Marie-Egyptienne DT and Hedley
DW: Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol.
19:106–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Signore M, Ricci-Vitiani L and De Maria R:
Targeting apoptosis pathways in cancer stem cells. Cancer Lett.
332:374–382. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chang L, Graham PH, Hao J, Bucci J, Cozzi
PJ, Kearsley JH and Li Y: Emerging roles of radioresistance in
prostate cancer metastasis and radiation therapy. Cancer Metastasis
Rev. 33:469–496. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ghisolfi L, Keates AC, Hu X, Lee DK and Li
CJ: Ionizing radiation induces stemness in cancer cells. PLoS One.
7:e436282012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lagadec C, Vlashi E, Donna L Della,
Dekmezian C and Pajonk F: Radiation-induced reprogramming of breast
cancer cells. Stem Cells. 30:833–844. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Krause M, Yaromina A, Eicheler W, Koch U
and Baumann M: Cancer stem cells: Targets and potential biomarkers
for radiotherapy. Clin Cancer Res. 17:7224–7229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Budach V, Stuschke M, Budach W, Baumann M,
Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann
T, et al: Hyperfractionated accelerated chemoradiation with
concurrent fluorouracil-mitomycin is more effective than
dose-escalated hyperfractionated accelerated radiation therapy
alone in locally advanced head and neck cancer: Final results of
the radiotherapy cooperative clinical trials group of the German
Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol.
23:1125–1135. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Baumann M, Herrmann T, Koch R, Matthiessen
W, Appold S, Wahlers B, Kepka L, Marschke G, Feltl D, Fietkau R, et
al: CHARTWEL-Bronchus studygroup: Final results of the randomized
phase III CHARTWEL-trial (ARO 97-1) comparing
hyperfractionated-accelerated versus conventionally fractionated
radiotherapy in non-small cell lung cancer (NSCLC). Radiother
Oncol. 100:76–85. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Baumann M, Krause M, Thames H, Trott K and
Zips D: Cancer stem cells and radiotherapy. Int J Radiat Biol.
85:391–402. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Baumann M, Krause M and Hill R: Exploring
the role of cancer stem cells in radioresistance. Nat Rev Cancer.
8:545–554. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Desai A, Webb B and Gerson SL: CD133+
cells contribute to radioresistance via altered regulation of DNA
repair genes in human lung cancer cells. Radiother Oncol.
110:538–545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kim YS, Kang MJ and Cho YM: Low production
of reactive oxygen species and high DNA repair: Mechanism of
radioresistance of prostate cancer stem cells. Anticancer Res.
33:4469–4474. 2013.PubMed/NCBI
|
|
56
|
Lagadec C, Vlashi E, Alhiyari Y, Phillips
TM, Dratver M Bochkur and Pajonk F: Radiation-induced Notch
signaling in breast cancer stem cells. Int J Radiat Oncol Biol
Phys. 87:609–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yoon CH, Kim MJ, Kim RK, Lim EJ, Choi KS,
An S, Hwang SG, Kang SG, Suh Y, Park MJ and Lee SJ: c-Jun
N-terminal kinase has a pivotal role in the maintenance of
self-renewal and tumorigenicity in glioma stem-like cells.
Oncogene. 31:4655–4666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kim MJ, Kim RK, Yoon CH, An S, Hwang SG,
Suh Y, Park MJ, Chung HY, Kim IG and Lee SJ: Importance of PKCδ
signaling in fractionated-radiation-induced expansion of
glioma-initiating cells and resistance to cancer treatment. J Cell
Sci. 124:3084–3094. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jamal M, Rath BH, Williams ES, Camphausen
K and Tofilon PJ: Microenvironmental regulation of glioblastoma
radioresponse. Clin Cancer Res. 16:6049–6059. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hovinga KE, Shimizu F, Wang R,
Panagiotakos G, Van Der Heijden M, Moayedpardazi H, Correia AS,
Soulet D, Major T, Menon J and Tabar V: Inhibition of notch
signaling in glioblastoma targets cancer stem cells via an
endothelial cell intermediate. Stem Cells. 28:1019–1029. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Bu Y and Cao D: The origin of cancer stem
cells. Front Biosci (Schol Ed). 4:819–830. 2012.PubMed/NCBI
|
|
62
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Usami Y, Satake S, Nakayama F, Matsumoto
M, Ohnuma K, Komori T, Semba S, Ito A and Yokozaki H:
Snail-associated epithelial-mesenchymal transition promotes
oesophageal squamous cell carcinoma motility and progression. J
Pathol. 215:330–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Trimboli AJ, Fukino K, de Bruin A, Wei G,
Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, et al:
Direct evidence for epithelial-mesenchymal transitions in breast
cancer. Cancer Res. 68:937–945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Brabletz T, Hlubek F, Spaderna S,
Schmalhofer O, Hiendlmeyer E, Jung A and Kirchner T: Invasion and
metastasis in colorectal cancer: Epithelial-mesenchymal transition,
mesenchymal-epithelial transition, stem cells and beta-catenin.
Cells Tissues Organs. 179:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Vergara D, Merlot B, Lucot JP, Collinet P,
Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal
transition in ovarian cancer. Cancer Lett. 291:59–66. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Liu J and Brown RE: Immunohistochemical
detection of epithelialmesenchymal transition associated with
stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp
Pathol. 3:755–762. 2010.PubMed/NCBI
|
|
68
|
Shang Y, Cai X and Fan D: Roles of
epithelial-mesenchymal transition in cancer drug resistance. Curr
Cancer Drug Targets. 13:915–929. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Jie D, Zhongmin Z, Guoqing L, Sheng L, Yi
Z, Jing W and Liang Z: Positive expression of LSD1 and negative
expression of E-cadherin correlate with metastasis and poor
prognosis of colon cancer. Dig Dis Sci. 58:1581–1589. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Battula VL, Evans KW, Hollier BG, Shi Y,
Marini FC, Ayyanan A, Wang RY, Brisken C, Guerra R, Andreeff M and
Mani SA: Epithelial-mesenchymal transition-derived cells exhibit
multilineage differentiation potential similar to mesenchymal stem
cells. Stem Cells. 28:1435–1445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Morel AP, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Santisteban M, Reiman JM, Asiedu MK,
Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC,
Manjili MH, et al: Immune-induced epithelial to mesenchymal
transition in vivo generates breast cancer stem cells. Cancer Res.
69:2887–2895. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
He E, Pan F, Li G and Li J: Fractionated
ionizing radiation promotes epithelial-mesenchymal transition in
human esophageal cancer cells through PTEN deficiency-mediated Akt
activation. PLoS One. 10:e01261492015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Marie-Egyptienne DT, Lohse I and Hill RP:
Cancer stem cells, the epithelial to mesenchymal transition (EMT)
and radioresistance: Potential role of hypoxia. Cancer Lett.
341:63–72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nagarajan D, Melo T, Deng Z, Almeida C and
Zhao W: ERK/GSK3β/Snail signaling mediates radiation-induced
alveolar epithelial-to-mesenchymal transition. Free Radic Biol Med.
52:983–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Su H, Jin X, Zhang X, Zhao L, Lin B, Li L,
Fei Z, Shen L, Fang Y, Pan H and Xie C: FH535 increases the
radiosensitivity and reverses epithelial-to-mesenchymal transition
of radioresistant esophageal cancer cell line KYSE-150R. J Transl
Med. 13:1042015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Li G, Liu Y, Su ZW, Ren SL, Liu C, Tian YQ
and Qiu YZ: Irradiation induced epithelial-mesenchymal transition
in nasopharyngeal carcinoma in vitro. Zhonghua Er Bi Yan Hou Tou
Jing Wai Ke Za Zhi. 48:662–667. 2013.(In Chinese). PubMed/NCBI
|
|
78
|
Kawamoto A, Yokoe T, Tanaka K, Saigusa S,
Toiyama Y, Yasuda H, Inoue Y, Miki C and Kusunoki M: Radiation
induces epithelial-mesenchymal transition in colorectal cancer
cells. Oncol Rep. 27:51–57. 2012.PubMed/NCBI
|
|
79
|
Kim E, Youn H, Kwon T, Son B, Kang J, Yang
HJ, Seong KM, Kim W and Youn B: PAK1 tyrosine phosphorylation is
required to induce epithelial-mesenchymal transition and
radioresistance in lung cancer cells. Cancer Res. 74:5520–5531.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yuan W, Yuan Y, Zhang T and Wu S: Role of
Bmi-1 in regulation of ionizing irradiation-induced
epithelial-mesenchymal transition and migration of breast cancer
cells. PLoS One. 10:e01187992015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yan S, Wang Y, Yang Q, Li X, Kong X, Zhang
N, Yuan C, Yang N and Kong B: Low-dose radiation-induced
epithelial-mesenchymal transition through NF-κB in cervical cancer
cells. Int J Oncol. 42:1801–1806. 2013.PubMed/NCBI
|
|
82
|
Al-Assar O, Demiciorglu F, Lunardi S,
Gaspar-Carvalho MM, McKenna WG, Muschel RM and Brunner TB:
Contextual regulation of pancreatic cancer stem cell phenotype and
radioresistance by pancreatic stellate cells. Radiother Oncol.
111:243–251. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Bastos LG, de Marcondes PG,
de-Freitas-Junior JC, Leve F, Mencalha AL, de Souza WF, de Araujo
WM, Tanaka MN, Abdelhay ES and Morgado-Díaz JA: Progeny from
irradiated colorectal cancer cells acquire an EMT-like phenotype
and activate Wnt/β-catenin pathway. J Cell Biochem. 115:2175–2187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y,
Zhang J, Yuan J, Wang M, Chen D, Sun Y, et al: ATM-mediated
stabilization of ZEB1 promotes DNA damage response and
radioresistance through CHK1. Nat Cell Biol. 16:864–875. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Jiang X, Wang J, Zhang K, Tang S, Ren C
and Chen Y: The role of CD29-ILK-Akt signaling-mediated
epithelial-mesenchymal transition of liver epithelial cells and
chemoresistance and radioresistance in hepatocellular carcinoma
cells. Med Oncol. 32:1412015. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhang X, Zheng L, Sun Y, Wang T and Wang
B: Tangeretin enhances radiosensitivity and inhibits the
radiation-induced epithelial-mesenchymal transition of gastric
cancer cells. Oncol Rep. 34:302–310. 2015.PubMed/NCBI
|
|
87
|
Wang L, Huang X, Zheng X, Wang X, Li S,
Zhang L, Yang Z and Xia Z: Enrichment of prostate cancer stem-like
cells from human prostate cancer cell lines by culture in
serum-free medium and chemoradiotherapy. Int J Biol Sci. 9:472–479.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Al-Assar O, Muschel RJ, Mantoni TS,
McKenna WG and Brunner TB: Radiation response of cancer stem-like
cells from established human cell lines after sorting for surface
markers. Int J Radiat Oncol Biol Phys. 75:1216–1225. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wang Y, Li W, Patel SS, Cong J, Zhang N,
Sabbatino F, Liu X, Qi Y, Huang P, Lee H, et al: Blocking the
formation of radiation-induced breast cancer stem cells.
Oncotarget. 5:3743–3755. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Vares G, Cui X, Wang B, Nakajima T and
Nenoi M: Generation of breast cancer stem cells by steroid hormones
in irradiated human mammary cell lines. PLoS One. 8:e771242013.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Aravindan S, Ramraj SK, Somasundaram ST,
Herman TS and Aravindan N: Polyphenols from marine brown algae
target radiotherapy-coordinated EMT and stemness-maintenance in
residual pancreatic cancer. Stem Cell Res Ther. 6:1822015.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Timmerman LA, Grego-Bessa J, Raya A,
Bertrán E, Pérez-Pomares JM, Díez J, Aranda S, Palomo S, McCormick
F, Izpisúa-Belmonte JC and de la Pompa JL: Notch promotes
epithelial-mesenchymal transition during cardiac development and
oncogenic transformation. Genes Dev. 18:99–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Leong KG, Niessen K, Kulic I, Raouf A,
Eaves C, Pollet I and Karsan A: Jagged1-mediated Notch activation
induces epithelial-to-mesenchymal transition through Slug-induced
repression of E-cadherin. J Exp Med. 204:2935–2948. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Sahlgren C, Gustafsson MV, Jin S,
Poellinger L and Lendahl U: Notch signaling mediates
hypoxia-induced tumor cell migration and invasion. Proc Natl Acad
Sci USA. 105:6392–6397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W,
Thilaganathan N, Alvarez CA, Moreira DC, Creighton CJ, Gregory PA,
et al: The Notch ligand Jagged2 promotes lung adenocarcinoma
metastasis through a miR-200-dependent pathway in mice. J Clin
Invest. 121:1373–1385. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Kim HJ, Litzenburger BC, Cui X, Delgado
DA, Grabiner BC, Lin X, Lewis MT, Gottardis MM, Wong TW, Attar RM,
et al: Constitutively active type I insulin-like growth factor
receptor causes transformation and xenograft growth of immortalized
mammary epithelial cells and is accompanied by an
epithelial-to-mesenchymal transition mediated by NF-kappaB and
snail. Mol Cell Biol. 27:3165–3175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Sosic D and Olson EN: A new twist on twist
- modulation of the NF-kappaB pathway. Cell Cycle. 2:76–78. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Rich JN: Cancer stem cells in radiation
resistance. Cancer Res. 67:8980–8984. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Mitra A, Mishra L and Li S: EMT, CTCs and
CSCs in tumor relapse and drug-resistance. Oncotarget.
6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
He YC, Zhou FL, Shen Y, Liao DF and Cao D:
Apoptotic death of cancer stem cells for cancer therapy. Int J Mol
Sci. 15:8335–8351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Dawood S, Austin L and Cristofanilli M:
Cancer stem cells: Implications for cancer therapy. Oncology
(Williston Park). 28:1101–1107, and 1110. 2014.PubMed/NCBI
|
|
103
|
Makki J, Myint O, Wynn AA, Samsudin AT and
John DV: Expression distribution of cancer stem cells, epithelial
to mesenchymal transition, and telomerase activity in breast cancer
and their association with clinicopathologic characteristics. Clin
Med Insights Pathol. 8:1–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ghisolfi L, Keates AC, Hu X, Lee DK and Li
CJ: Ionizing radiation induces stemness in cancer cells. PLoS One.
7:e436282012. View Article : Google Scholar : PubMed/NCBI
|
